This settlement is closed!
Please see what other class action settlements you might qualify to claim cash from in our Open Settlements directory!
Update:
- Final approval for this class action settlement was granted Dec. 4, 2023.
- Let Top Class Actions know when you receive a check in the comments section below or on our Facebook page.
Indivior agreed to a $30 million antitrust class action lawsuit settlement to resolve claims that it worked with other companies to raise the cost of Suboxone, a treatment for opioid addiction.
The settlement benefits individuals and entities who indirectly purchased or paid for Suboxone and its AB-rated generic equivalents for themselves, their families, employees, plan participants, beneficiaries or insureds between Dec. 22, 2011 and Aug. 21, 2023, in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia.
The antitrust class action lawsuit accused Indivior of conspiring with other companies to raise the price of Suboxone and its generic alternatives. According to the plaintiffs in the case, they were forced to overpay for Suboxone as a result of the antitrust scheme.
Individor is a pharmaceutical company that specializes in addiction and mental health treatment.
Indivior hasn’t admitted any wrongdoing but agreed to a $30 million settlement to resolve the antitrust class action lawsuit.
Under the terms of the Suboxone class action settlement, class members can receive a proportional share of the net settlement fund based on the amount they spent in qualifying purchases. Exact payments will vary depending on the number of claims filed and other factors.
The deadline for exclusion is Oct. 12, 2023. The objection deadline is Oct. 5, 2023.
The final approval hearing for the Suboxone antitrust class action lawsuit settlement is scheduled for Oct. 19, 2023.
In order to receive a settlement payment, class members must submit a valid claim form by Feb. 17, 2024.
Who’s Eligible
Individuals and entities who indirectly purchased or paid for Suboxone and its AB-rated generic equivalents for themselves, their families, employees, plan participants, beneficiaries or insureds between Dec. 22, 2011, and Aug. 21, 2023, in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia
Potential Award
Varies
Proof of Purchase
Records from the class member’s pharmacy showing they purchased Suboxone and its AB‐rated generic equivalents at least once or a note or records from their doctor describing the amount of Suboxone and its AB‐rated generic equivalents prescribed.
Class members may have a claim even if they are not able to provide any of the above claim documentation as long as they provide the certification on the claim form. However, the settlement administrator may ask those who do not provide the above documentation for additional claim documentation after the class member submits their claim form.
Claim Form
NOTE: If you do not qualify for this settlement do NOT file a claim.
Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.
Claim Form Deadline
02/17/2024
Case Name
In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation, Case No. 2:13-md-02445-MSG, in the U.S. District Court for the Eastern District of Pennsylvania
Final Hearing
10/19/2023
Settlement Website
Claims Administrator
Suboxone End-Payor Antitrust Litigation
c/o A.B. Data, Ltd.
P.O. Box 173080
Milwaukee, WI 53217
[email protected]
877-311-3735
Class Counsel
Kenneth A Wexler
WEXLER BOLEY & ELGERSMA LLP
Steve Shadowen
HILLIARD SHADOWEN LLP
Michael M. Buchman
MOTLEY RICE LLC
Marvin A Miller
MILLER LAW LLC
Jeffrey L Kodroff
SPECTOR ROSEMAN & KODROFF PC
Defense Counsel
Justin Bernick
HOGAN LOVELLS US LLP
Read About More Class Action Lawsuits & Class Action Settlements:
- CVS lidocaine false advertising $3.8M class action settlement
- Allwell Behavioral Health data breach $650K class action settlement
- Right Guard antiperspirant $1.95M class action settlement
- Instagram BIPA $68.5M class action settlement
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
339 thoughts onSuboxone indirect purchasers antitrust $30M class action settlement
Guess the judge wants to approve the denied claims and apparently she needs 35 court dates and a decade to make a decision. It’s actually strange. Either she’s still getting accustomed to her new position or she’s helping the attorneys stack up that interest baby.
What are the 2 new motions filed on 2/26/2026? They are not yet signed by the judge but are withdraw of 2 attorneys.
I don’t know, but I can’t stand till people wait till the last minute and hold everybody else’s money up this has been going on since 2023. I’ve never seen a last for so many people want end at the last minute.
The amount of ignorance in these forums is shocking. Blaming the attorneys or AB Data is dumb. It is not their fault. The problem with this case is that the judge is arguing with AB Data, and is pushing them to pay rejected claims – some that claimed millions. The judge doesn’t understand that most people who file for settlements like this are complete frauds who steal money from the actual victims. If AB Data loses this fight, expect your payment amounts to plummet. Most of the people who post here are frauds anyway. So you should be happy for anything you receive, whenever you receive it. And what difference does it matter when you get your free money? There is literally nothing any of you can do to speed up this process. In fact, all of the emailing and calling probably slows it down. All you have to do is read their website. If there’s no update there, then there’s no update. Just sit back and relax, and hope that AB Data convinces the judge that some of your fellow frauds’ claims will remain rejected.
Stfu
Ok professor
I think that the people that are really truly involved in this case have been waiting for three years now and they’re just really frustrated. I don’t think this is free money because you can’t get free money from this lawsuit so please try to be nice. These people have at least had two years to know they were either qualified or disqualified. I think what’s upsetting people as they wait till it gets in front of the judge before it’s supposed to be distributed then hollers oh I
I wasn’t approved. Well I wasn’t approved at first. I had to prove myself and I got it straightened out before it went to court.
Geez. Someone’s grouchy and giving bad advice.
Free money??
Dumb thing to say.
Amendment to the previous 2/12 comment: Unfortunately, the financials are actually a bit worse than what was previously stated. The Repealer and non-Repealer buckets ($15.0M and $1.67 M, respectively) are each FURTHER allocated 45% to consumers (“Consumer Pool”) and 55% to Third Party Payors (“TPP Pool”). That makes the Consumer Pools $6.75M (Repealer) and $750K (non-Repealer) which results in a final payment amount of (approx) $750 regardless of which pool is applicable to the claimant. As to the question of “Pro Rata”, we have seen this term used in class actions to frequently mean “proportional” to the number of claimants and not necessarily proportional to the claim amounts. To be clear, we don’t know definitively which methodology AB Data is using. So, yes, assuming the “claim amount” methodology any claim over $5K should likely get more than $750, and those with claim amounts less than $5K would get less. Please refer to the “Cort Documents” on the AB Data website, and feel free to verify/check our numbers. We sincerely apologize for any confusion.
Do you work on the case? Is the verified by the class administration?